NCT04882995

Brief Summary

Post-operative constipation is one of the most common complaints after pelvic organ prolapse surgery. Psyillum fiber is an FDA-approved, over the counter dietary supplement that is commonly used to treat constipation. The investigators are conducting this study to determine if participants who receive psyllium fiber before surgery have less difficulty with their first bowel movement after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 13, 2019

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

May 6, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 12, 2021

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2021

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

June 28, 2022

Completed
Last Updated

June 28, 2022

Status Verified

June 1, 2022

Enrollment Period

2 years

First QC Date

May 6, 2021

Results QC Date

November 23, 2021

Last Update Submit

June 25, 2022

Conditions

Keywords

Postoperative constipation

Outcome Measures

Primary Outcomes (1)

  • Time to First Bowel Movement After Surgery

    Date and time of first bowel movement captured via postoperative bowel diary

    Within 7 days

Secondary Outcomes (1)

  • Pain Associated With First Bowel Movement After Surgery

    Within 7 days

Study Arms (2)

Intervention - Received fiber

EXPERIMENTAL

Participants received 14 doses of psyllium fiber packet (Metamucil, 3.4g). They were instructed to take 1 packet twice a day beginning 7 days before surgery.

Dietary Supplement: Psyillium fiber

Control - Did not receive fiber

NO INTERVENTION

Participants did not take any preoperative fiber.

Interventions

Psyillium fiberDIETARY_SUPPLEMENT

Participants receive 7 days of psyllium fiber dietary supplement prior to scheduled surgery

Intervention - Received fiber

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women undergoing prolapse repair with or without hysterectomy on the University of Massachusetts urogynecology service

You may not qualify if:

  • Unable to provide consent
  • Under 18 years of age
  • Pregnant women
  • Prisoners
  • As our validated questionnaires are only available in English, we are unable to offer study participation to Non-English speaking subjects
  • Because these conditions intrinsically affect bowel function, women with the following will be excluded: history of inflammatory bowel disease, colorectal cancer, rectovaginal fistula, sigmoid resection or rectal surgery
  • Because the use of motility agents can affect bowel function and stool transit, women using motility agents such as linaclotide will be excluded.
  • Concurrent bowel surgery due to potential effect on the surgical field
  • Concurrent anal sphincteroplasty due to potential effect on the surgical field
  • Insulin-dependent diabetes mellitus with known gastroparesis as this would affect transit of fiber supplement
  • Patients with a history of phenylketonuria as the psyllium fiber supplement we will be using contains phenylalanine
  • History of placement of sacral neuromodulating device for indication of fecal incontinence, as this would affect bowel function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Massachusetts Memorial Medical Center

Worcester, Massachusetts, 01605, United States

Location

Related Publications (6)

  • Ramaseshan AS, LaSala C, O'Sullivan DM, Steinberg AC. Patient-Initiated Telephone Calls in the Postoperative Period After Female Pelvic Reconstructive Surgery. Female Pelvic Med Reconstr Surg. 2020 Oct;26(10):626-629. doi: 10.1097/SPV.0000000000000636.

    PMID: 30247168BACKGROUND
  • Patel M, Schimpf MO, O'Sullivan DM, LaSala CA. The use of senna with docusate for postoperative constipation after pelvic reconstructive surgery: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 2010 May;202(5):479.e1-5. doi: 10.1016/j.ajog.2010.01.003. Epub 2010 Mar 6.

    PMID: 20207340BACKGROUND
  • McNanley A, Perevich M, Glantz C, Duecy EE, Flynn MK, Buchsbaum G. Bowel function after minimally invasive urogynecologic surgery: a prospective randomized controlled trial. Female Pelvic Med Reconstr Surg. 2012 Mar-Apr;18(2):82-5. doi: 10.1097/SPV.0b013e3182455529.

    PMID: 22453316BACKGROUND
  • Arya LA, Novi JM, Shaunik A, Morgan MA, Bradley CS. Pelvic organ prolapse, constipation, and dietary fiber intake in women: a case-control study. Am J Obstet Gynecol. 2005 May;192(5):1687-91. doi: 10.1016/j.ajog.2004.11.032.

    PMID: 15902178BACKGROUND
  • Ballard A, Parker-Autry C, Lin CP, Markland AD, Ellington DR, Richter HE. Postoperative bowel function, symptoms, and habits in women after vaginal reconstructive surgery. Int Urogynecol J. 2015 Jun;26(6):817-21. doi: 10.1007/s00192-015-2634-8. Epub 2015 Feb 12.

    PMID: 25672646BACKGROUND
  • Maheshwari D, Hall CD, Jia X, Tangada A, Wu EK, Leung K, Flynn MK. The Effect of Preoperative Fiber on Postoperative Bowel Function After Pelvic Reconstructive Surgery: A Randomized Controlled Trial. Urogynecology (Phila). 2022 Aug 1;28(8):554-560. doi: 10.1097/SPV.0000000000001203. Epub 2022 May 24.

MeSH Terms

Conditions

ConstipationUterine Prolapse

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPelvic Organ ProlapseProlapsePathological Conditions, Anatomical

Results Point of Contact

Title
Dr. Deepali Maheshwari
Organization
UMass Chan Medical School

Study Officials

  • Deepali Maheshwari, DO, MPH

    UMass Chan Medical School

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Instructor

Study Record Dates

First Submitted

May 6, 2021

First Posted

May 12, 2021

Study Start

May 13, 2019

Primary Completion

May 28, 2021

Study Completion

June 1, 2021

Last Updated

June 28, 2022

Results First Posted

June 28, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations